Coronary and valvular syndromes and antiphospholipid antibodies

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 501-507

  Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Coronary artery disease; Lupus anticoagulant; Valvular disease

Indexed keywords

ANTICOAGULANT AGENT; PHOSPHOLIPID ANTIBODY; STEROID;

ANGINA PECTORIS; ANGIOPLASTY; ANTIPHOSPHOLIPID SYNDROME; BACTERIAL ENDOCARDITIS; BLOOD CLOTTING DISORDER; CARDIOMYOPATHY; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; GRAFT OCCLUSION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRACARDIAC THROMBOSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; THROMBOSIS; VALVULAR HEART DISEASE;

EID: 7044224347     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.026     Document Type: Article

References (60)

1. S. Manzi, E.N. Meilhan, J. Rairie, C.G. Conte, T.A. Medsger Jr., and L. Jansen-McWilliams Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus comparison with the Framingham Study Am. J. Epidemiol. 145 1997 408 415
2. M. Petri, C. Lakatta, L. Magder, and D.W. Goldman Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis Am. J. Med. 96 1994 254 259
3. A. Karrar, W. Sequeira, and J.A. Block Coronary artery disease in systemic lupus erythematosus: a review of the literature Semin. Arthritis Rheum. 30 2001 436 443
4. R.A. Asherson, and R. Cervera Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist Circulation 84 1991 920 923
5. M. Petri Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort Lupus 9 2000 170 175
6. R.A. Asherson, E.N. Harris, A.E. Gharavi, and G.R.V. Hughes Myocardial infarction in SLE and 'lupus-like' disease Arthritis Rheum. 29 1985 1292 1293
7. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients Arthritis Rheum. 46 2002 1019 1027
8. O. Vaarala, M. Mänttäri, V. Manninen, L. Tenkanen, M. Puurunen, and K. Aho Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men Circulation 91 1995 23 27
9. M. Puurunen, M. Manttari, V. Manninen, L. Tenkanen, G. Alfthan, and C. Ehnholm Antibodies to oxidized low-density lipoprotein predicting myocardial infarction Arch. Intern. Med. 154 1994 2605 2609
10. L. Iuliano, D. Pratico, D. Ferro, V. Pittoni, G. Valesini, and J. Lawson Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies Blood 90 1997 3931 3935
11. O. Vaarala Antiphospholipid antibodies and myocardial infarction Lupus 7 Suppl. 2 1998 132 134
12. A. Hamsten, R. Norberg, M. Bjorkholm, U. DeFirre, and G. Holm Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events Lancet 1 1986 113 116
13. S.R. Levine, L. Salowich-Palm, K.L. Sawaya, M. Perry, H.J. Spencer, and H.J. Winkler IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study Stroke 28 1997 1660 1665
14. Y. Adler, Y. Finkelstein, G. Zandeman-Goddard, M. Blank, M. Lorber, and A. Lorber The presence of antiphospholipid antibodies in acute myocardial infarction Lupus 4 1995 309 313
15. E. Zuckerman, E. Toubi, A. Shiran, E. Sabo, Z. Shmuel, and T.D. Golan Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythematosus patients: a controlled prospective study Am. J. Med. 171 1996 381 386
16. G. Espinosa, R. Cervera, J. Font, M. García-Carrasco, C. Battagliotti, and M. Ingelmo Cardiac and pulmonary manifestations in the antiphospholipid syndrome R.A. Asherson R. Cervera J.C. Piette Y. Shoenfeld The antiphospholipid syndrome II-autoimmune thrombosis 2002 Elsevier Amsterdam 169 188
17. R. Wu, S. Nityanand, L. Berglund, H. Lithell, G. Holm, and A.K. Lefvert Antibodies against cardiolipin and oxidatively modified LDL in 50-year old men predict myocardial infarction Arterioscler. Thromb. Vasc. Biol. 17 1997 3159 3163
18. K.E. Sletnes, P. Smith, M. Abdelnoor, H. Arnesen, and F. Wisloff Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke Lancet 339 1992 451 453
19. K.V. Phadke, R.A. Phillips, D.T. Clarke, M. Jones, P. Naish, and P. Carson Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br. Heart J. 69 1993 391 394
20. A. Bili, A.J. Moss, C.W. Francis, W. Zareba, and L.F. Miller Watelet Anticardiolipin antibodies and recurrent coronary events. A prospective study of 1150 patients Circulation 102 2000 1258 1263
21. R. De Caterina, A. D'Ascanio, A. Mazzone, P. Gazzaetti, W. Bernini, and R. Neri Prevalence of anticardiolipin antibodies in coronary artery disease Am. J. Cardiol. 65 1989 922 923
22. O. Vaarala Antiphospholipid antibodies and atherosclerosis Lupus 5 1996 442 447
23. W.F. Baker Jr., and R.L. Bick Antiphospholipid antibodies in coronary artery disease: a review Semin. Thromb. Hemost. 20 1994 27 45
24. S. Takeuchi, T. Obayashi, and J. Toyama Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA Heart 79 1998 96 98
25. A. Fernández Ballesteros, F. Zancada Díaz de Entresotos, A. Roldan Montaud, and J. Jiménez Jiménez Anticuerpos antifosfolípido y angor An. Med. Intern. (Madrid) 7 1990 383 384
26. M.N. Díaz, and R.C. Becker Anticardiolipin antibodies in patients with unstable angina Cardiology 84 1994 380 384
27. A. Farsi, M.P. Domeneghetti, S. Fedi, M. Capanni, B. Giusti, and R. Marcucci High prevalence of anti-beta2-glycoprotein I antibodies in patients with ischemic heart disease Autoimmunity 30 1999 93 98
28. R.L. Bick, Y. Ismail, and W.F. Baker Jr. Coagulation abnormalities in patients with precocious coronary artery thrombosis and patients failing coronary artery bypass grafting and percutaneous transcoronary angioplasty Semin. Thromb. Hemost. 19 1993 411 417
29. T.P. Gavaghan, S.A. Krilis, G.E. Daggard, D.E. Baron, J.B. Hickie, and C.N. Chesterman Anticardiolipin antibodies and occlusion of coronary bypass grafts Lancet 2 1987 977 978
30. K.E. Morton, T.P. Gavaghan, S.A. Krilis, G.E. Daggard, D.W. Baron, and J.B. Hickie Coronary artery bypass graft failure: an autoimmune phenomenon? Lancet 2 1986 1353 1356
31. B. Eber, M. Schumacher, P. Auer-Grumbach, H. Toplak, and W. Klein Increased IgM anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty Am. J. Cardiol. 69 1992 1255 1258
32. J.D. Chambers, W.D. Haire, and U. Deligonul Multiple early percutaneous transluminal coronary angioplasty failures related to lupus anticoagulant Am. Heart J. 132 1996 189 190
33. C. Ludia, P. Domenico, C. Monia, A. Emilia, F. Sandra, and A.L. Agatina Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? Autoimmunity 27 1998 141 148
34. M. Jankowski, D. Didek, J.S. Dubiel, and J. Musial Successful coronary stent implantation in a patient with primary antiphospholipid syndrome Blood Coagul. Fibrinolysis 9 1998 753 756
35. C.V. Umesan, A. Kapoor, S. Nityanand, S. Tiwari, and N. Sinha Recurrent acute coronary events in a patient with primary antiphospholipid syndrome: successful management with intracoronary stenting Int. J. Cardiol. 71 1999 99 102
36. M.A. Khamashta, R. Cervera, R.A. Asherson, J. Font, A. Gil, and D.J. Coltart Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus Lancet 335 1990 1541 1544
37. P. Nyhoyannopoulos, P.M. Gomez, J. Joshi, S. Loizou, M.J. Walport, and C.M. Oakley Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies Circulation 82 1990 369 375
38. R. Cervera, J. Font, C. Paré, M. Azqueta, F. Pérez-Villa, and A. López-Soto Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients Ann. Rheum. Dis. 51 1992 156 159
39. C.A. Roldan, B.K. Shively, C.C. Lau, F.T. Gurule, E.A. Smith, and M.H. Crawford Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies J. Am. Coll. Cardiol. 20 1992 1127 1134
40. E. Galve, J. Ordi, J. Barquinero, A. Evangelista, M. Vilardell, and J. Soler-Soler Valvular heart disease in the primary antiphospholipid syndrome Ann. Intern. Med. 116 1992 293 298
41. R. Cervera, M.A. Khamashta, J. Font, P.A. Reyes, J.L. Vianna, and A. López-Soto High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome Lupus 1 1991 43 47
42. G. Nesher, J. Ilany, D. Rosenmann, and A.S. Abraham Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment Semin. Arthritis Rheum. 27 1997 27 35
43. J.L. Vianna, M.A. Khamashta, J. Ordi-Ros, J. Font, R. Cervera, and A. López-Soto Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients Am. J. Med. 96 1994 3 9
44. B. Brenner, Z. Blumenfeld, W. Markiewicz, and S.A. Reisner Cardiac involvement in patients with primary antiphospholipid syndrome J. Am. Coll. Cardiol. 18 1991 931 936
45. M. Turiel, S. Muzzupappa, B. Gottardi, C. Crema, P. Sarzi-Puttini, and E. Rossi Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography Lupus 9 2000 406 412
46. N. Espínola-Zavaleta, J. Vargas-Barron, T. Comenares-Galvis, F. Cruz-Cruz, A. Romero-Cárdenas, and C. Keirns Echocardiographic evaluation of patients with primary antiphospholipid syndrome Am. Heart J. 137 1999 973 979
47. R.A.P. Skyrme-Jones, C.A.J. Wardrop, C.M. Wiles, and A.G. Fraser Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with the primary antiphospholipid syndrome J. Am. Soc. Echocardiogr. 8 1995 251 256
48. M.Z. Jafar, M.C. Morgan, and J. Gorcsan III Transesophageal echocardiographic detection of multiple valve masses in primary antiphospholipid syndrome with stroke Am. Heart J. 127 1994 445 446
49. Pérez-Villa F, Font J, Azqueta M, Paré C, Cervera R, Reverter JC, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus. A prospective, long-term follow-up study. Ann Rheum Dis [in press].
50. L. Ziporen, I. Goldberg, M. Arad, M. Hojnik, J. Ordi-Ros, and A. Afek Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves Lupus 5 1996 196 205
51. H. Amital, P. Langevitz, Y. Levy, A. Afek, I. Goldberg, and M. Pras Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease Clin. Exp. Rheumatol. 17 1999 99 102
52. A. Afek, Y. Shoenfeld, R. Manor, I. Goldberg, L. Ziporen, and J. George Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome Lupus 8 1999 502 507
53. R. García-Torres, M.C. Amigo, A. de la Rosa, A. Morón, and P.A. Reyes Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings Lupus 5 1996 56 61
54. J.G. D'Alton, D.N. Preston, J. Bormanis, M.S. Green, and G.R. Kraag Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis Stroke 16 1985 512 514
55. J.M. Pope, C.L.B. Canny, and D.A. Bell Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant Am. J. Med. 90 1991 299 309
56. M.A. Agirbasli, D.E. Hansen, and B.F. Byrd III Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome J. Am. Soc. Echocardiogr. 10 1997 877 880
57. D. O'Neill, J. Magaldi, D. Dobkins, and T. Greco Dissolution of intracardiac mass lesions in the primary antiphospholipid syndrome Arch. Intern. Med. 155 1995 325 327
58. L.I. Kupferwasser, G. Hafner, S. Mohr-kahaly, R. Erbel, J. Meyer, and H. Darius The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events J. Am. Coll. Cardiol. 33 1999 1365 1371
59. R.A. Asherson, D.G. Gibson, D.W. Evans, E. Baguley, and G.R.V. Hughes Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions and transient ischaemic attacks Ann. Rheum. Dis. 47 1988 947 953
60. J. Font, R. Cervera, C. Paré, A. López-Soto, L. Pallarés, and M. Azqueta Haemodynamically significant non-infective verrucous endocarditis in a patient with 'primary' antiphospholipid syndrome Br. J. Rheumatol. 30 1991 305 307